Saturday 17 October 2026
Export AHG’s income statement to Excel — free account
Akso Health Group Sponsored ADR
AHG Healthcare Medical Distribution
Akso Health Group Sponsored ADR’s revenue for fiscal 2026 (year ended March 2026) was $13.8 million, down 6.40% from fiscal 2025.
1.35
0.00
0.00%
Follow AHG
| Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | Mar '24 | Mar '25 | Mar '26 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
7.48 | 7.88 | 27.83 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
— | 7 | 1 | 2 | 3 | 4 | 4 | 4 | 4 | 5 |
Altman Z-Score |
— | 16.66 | 3.59 | (0.84) | (2.75) | (0.58) | (4.45) | 9.49 | 10.01 | 112.75 |
P/S ratio |
0.00 | 4.79 | 2.65 | 1.32 | 2.56 | 3.43 | 0.30 | 0.92 | 0.95 | 1.84 |
Altman Z″-Score (non-manufacturers) |
14.00 | 16.39 | 7.04 | 0.93 | (5.32) | (1.48) | (9.73) | 44.96 | 10.58 | 23.59 |
P/FCF ratio |
6.16 | 4.81 | 1.78 | 0.49 | 0.68 | 0.68 | 0.00 | 0.00 | 1.42 | 0.00 |
P/Operating CF |
13.19 | 41.39 | 13.09 | 1.65 | 2.30 | 2.21 | 0.47 | 1.49 | (3.96) | 30.09 |
Beneish M-Score |
— | 0.33 | (2.33) | 3.62 | (9.62) | 3.88 | (4.58) | — | — | — |
P/B ratio |
4.99 | 3.67 | 1.29 | 0.20 | 1.66 | 2.24 | 0.67 | 3.48 | 0.10 | 0.19 |
Price to Tangible BV |
4.99 | 3.67 | 1.29 | 0.20 | 1.66 | 2.24 | 0.67 | 3.48 | 0.22 | 0.21 |
EV/Sales |
0.00 | 3.56 | 2.04 | 1.69 | 3.05 | 3.28 | 0.96 | 1.49 | (2.36) | 2.51 |
EV/EBITDA |
0.00 | 5.02 | 24.57 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.57 | 0.00 |
EV/Operating CF |
4.87 | 3.54 | 1.35 | 0.60 | 0.78 | 0.62 | (1.57) | (2.41) | (3.15) | 2.98 |
EV/FCF |
4.94 | 3.57 | 1.37 | 0.62 | 0.81 | 0.65 | (1.37) | (2.12) | (3.52) | (0.32) |
Quick Ratio |
4.80 | 6.79 | 3.55 | 3.47 | 2.05 | 1.00 | 1.34 | 23.70 | 13.69 | 0.17 |
Current Ratio |
5.65 | 6.84 | 3.68 | 4.21 | 2.09 | 1.24 | 1.76 | 39.52 | 14.20 | 21.77 |
Net Debt/EBITDA |
(1.92) | (1.74) | (6.79) | (0.31) | 0.18 | 7.50 | 0.56 | 9.86 | 1.07 | (0.01) |
Debt/Assets |
0.00% | 0.00% | 11.54% | 25.77% | 31.56% | 0.00% | 0.00% | 0.00% | 0.00% | 0.18% |
Debt/Equity |
0.00 | 0.00 | 0.16 | 0.43 | 0.58 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
1.62 | 1.12 | 0.36 | 0.05 | 0.03 | 0.13 | 0.32 | 0.03 | 0.08 | 0.07 |
Operating CF/Net income |
0.96 | 1.34 | (0.31) | 0.82 | (0.29) | 0.51 | 2.39 | (0.14) | (0.01) | 0.69 |
Capex/Depreciation |
(3.12) | (2.61) | (2.31) | (1.60) | 0.00 | (0.27) | — | — | (0.07) | (74.07) |
Interest Coverage |
— | — | — | (18.25) | (13.34) | (3.05) | — | — | — | — |
| 45.69% | 80.08% | 4.15% | (81.55%) | (106.55%) | (114.02%) | (12.87%) | (12.85%) | (79.97%) | (9.83%) | |
| 60.40% | 68.11% | 3.28% | (56.12%) | (62.10%) | (35.67%) | (3.27%) | (11.64%) | (75.62%) | (9.23%) | |
ROIC |
145.03% | 639.06% | 3.57% | (48.36%) | (159.07%) | 0.00% | (974.52%) | (10.14%) | (453.47%) | (7.14%) |
Return on Tangible Assets |
37.10% | 46.76% | 7.64% | (179.12%) | (220.77%) | (136.55%) | (15.38%) | (6.83%) | (74.03%) | (10.32%) |
Average Days of Receivables |
66.60 | 99.54 | 220.04 | 1,912.89 | 2,992.82 | 1,954.37 | 213.13 | 0.00 | 318.51 | 33.81 |
Research and Development Expense of Revenue |
22.47% | 7.92% | 12.06% | 14.93% | 31.03% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
34.28% | 21.34% | 79.63% | 322.50% | 1,616.05% | 51.03% | 117.86% | 362.85% | 24.64% | 28.84% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.09 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 1.71% | 10.74% | 5.03% | 3.16% | 6.53% | 0.00% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
0.20 | 0.27 | 0.31 | 0.24 | 1.17 | (0.59) | 1.58 | 0.29 | 4.58 | 0.13 |
Graham Number |
0.00 | 30.24 | 7.95 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Earnings Yield |
13.36% | 12.69% | 3.59% | (119.07%) | (101.15%) | (58.58%) | (86.11%) | (15.79%) | (15.25%) | (7.89%) |
Free Cash Flow Yield |
16.22% | 20.78% | 56.15% | 204.97% | 146.74% | 147.45% | (232.63%) | (76.47%) | 70.34% | (431.95%) |
Revenue per Share |
1.62 | 7.15 | 3.78 | 0.43 | 0.11 | 0.30 | 0.58 | 0.05 | 0.05 | 0.02 |
Operating CF per Share |
0.58 | 5.85 | (0.11) | (3.59) | 0.62 | (0.43) | (0.14) | 0.03 | 0.00 | (0.02) |
Capex per Share |
(0.02) | (0.03) | (0.06) | (0.01) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (0.24) |
Free Cash Flow per Share |
0.56 | 5.82 | (0.16) | (3.60) | 0.62 | (0.43) | (0.14) | 0.03 | 0.00 | (0.26) |
Cash per Share |
1.36 | 8.85 | 3.54 | 0.41 | 0.93 | 0.93 | 0.35 | 1.81 | 0.62 | 0.00 |
Shareholders Equity per Share |
1.67 | 9.34 | 7.79 | 2.96 | 1.06 | 0.62 | 0.39 | 2.93 | 0.70 | 0.25 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.67 | 9.34 | 7.79 | 2.96 | 1.06 | 0.62 | 0.39 | 2.93 | 0.70 | 0.25 |
Free Cash Flow |
7.90 | 87.27 | (2.67) | (58.47) | 10.06 | (8.63) | (3.25) | 1.35 | 1.02 | (188.46) |
Working Capital |
22.68 | 139.28 | 71.12 | 39.66 | 15.71 | 12.29 | 8.84 | 138.42 | 182.31 | 180.84 |
Capital Expenditures |
(0.29) | (0.46) | (0.94) | (0.19) | — | 0.00 | — | — | (0.15) | (175.67) |
Net Current Asset Value |
22.68 | 139.28 | 50.93 | 19.64 | 15.71 | 12.29 | 8.84 | 138.42 | 180.32 | 180.84 |
EV/EBIT |
0.00 | 5.03 | 24.57 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.57 | 0.00 |
Capex to Sales |
0.01 | 0.00 | 0.02 | 0.03 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 12.70 |
Price to Operating Income |
0.00 | 6.77 | 31.90 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.22 | 0.23 | 0.32 | 1.30 | 0.23 | 0.33 | — | — | 133.53 | 197.63 |
Cash ROIC |
18.49% | 32.01% | (1.31%) | (77.44%) | 23.72% | (28.11%) | (19.41%) | 0.60% | 0.27% | (103.87%) |
Accounts Receivable Turnover |
1.37 | 6.42 | 1.85 | 0.19 | 0.07 | 0.26 | 0.66 | 0.00 | 1.44 | 1.95 |
Accounts Payable Turnover |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | — | — | 0.00 | 2.51 | 2.44 | 78.97 | 70.94 |
Average Days of Payables |
— | — | — | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | — | — | 527.44 | 51.67 | 30.45 | 4.61 | 5.28 |
Average Receivables |
16.72 | 16.72 | 33.11 | 36.61 | 25.31 | 23.26 | 19.91 | — | 10.30 | 7.09 |
Average Inventory |
— | — | — | — | — | — | 4.74 | 0.94 | 0.19 | 0.20 |
Average Assets |
14.19 | 96.14 | 168.57 | 126.87 | 56.08 | 47.25 | 41.63 | 81.24 | 178.49 | 202.29 |
Average Common Equity |
18.76 | 81.77 | 133.27 | 87.30 | 32.69 | 14.78 | 10.56 | 73.63 | 168.79 | 190.04 |
Columns are period end dates